Johnson & Johnson (NYSE: JNJ) last traded at $263.73, up 0.88% on the session. The quote above updates while this page is open; the figures below are drawn from Johnson & Johnson’s own filings and are restated only when a new one is published.
Johnson & Johnson trades on NYSE under the ticker JNJ. It is classified in the Healthcare sector, Pharmaceuticals industry. Its market capitalisation is $635.56 billion.
Healthcare sectorPharmaceuticalsListed on NYSE
Valuation measures for Johnson & Johnson, derived from the latest quote and its most recent SEC filing.
| Market cap | $635.56B |
|---|---|
| Enterprise value | $731.23B |
| P/E ratio | 30.63 |
| Price / sales | 6.49 |
| Price / book |
|---|
| 7.48 |
| Beta | -0.19 |
|---|
Trailing-twelve-month figures tagged in Johnson & Johnson's XBRL filings with the SEC.
| Revenue (TTM) | $97.93B |
|---|---|
| Net income (TTM) | $21.04B |
| EPS (TTM) | $8.61 |
| Gross margin | 67.91% |
| Return on equity | 24.76% |
| Cash | $20.42B |
Range and volume for JNJ over the past 52 weeks.
| 52-week high | $281.07 |
|---|---|
| 52-week low | $184.66 |
| Volume | 5.64M |
| Average volume | 6.98M |
| Previous close | $261.44 |
Dividend history for Johnson & Johnson over the trailing twelve months.
| Dividend yield | 1.99% |
|---|---|
| Dividend per share (TTM) | $5.24 |
| Payout ratio | 60.86% |
Other Healthcare companies tracked on FurlPay Markets.
Invest a chosen dollar amount in Johnson & Johnson with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell JNJ.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.